Abstract | OBJECTIVE:
Low-density lipoproteins ( LDL) in inflamed synovium is oxidized and taken-up by synoviocytes. In this study, we investigate whether direct injection of oxidized LDL ( oxLDL) into a normal murine knee joint induces joint pathology and whether synovial macrophages are involved in that process. DESIGN: Synovium was obtained from end-stage osteoarthritis (OA) patients in order to analyze LDL-uptake. Murine knee joints were injected five consecutive days with oxLDL, LDL, or vehicle ( phosphate buffered saline (PBS)). This procedure was repeated in mice depleted of synovial macrophages by intra-articular injection of clodronate liposomes 7 days prior to the consecutive injections. Joint pathology was investigated by immunohistochemistry, flow cytometry (FCM) and synovial RNA expression and protein production. RESULTS: Synovial tissue of OA patients showed extensive accumulation of apolipoprotein B. Multiple injections of oxLDL in murine knee joints significantly increased TGF-β activity in synovial wash-outs, but did not induce catabolic or inflammatory processes. In contrast, repeated injections of oxLDL in macrophage-depleted knee joints led to increased synovial thickening in combination with significantly upregulated protein and RNA levels of CCL2 and CCL3. FCM-analyses revealed increased presence of monocytes and neutrophils in the synovium, which was confirmed by immunohistochemistry. Also protein levels of S100A8/A9 were significantly increased in synovial wash-outs of oxLDL-injected joints, as was expression of aggrecanase-induced neo- epitopes. Interestingly, no raise in TGF-β concentrations was measured in macrophage-depleted joints. CONCLUSIONS:
OxLDL can affect joint pathology, since synovial macrophages promote anabolic processes after oxLDL injections. In absence of synovial macrophages, however, oxLDL induces production of pro-inflammatory mediators and aggrecanase activity combined with increased influx of monocytes and neutrophils.
|
Authors | W de Munter, E J W Geven, A B Blom, B Walgreen, M M A Helsen, L A B Joosten, J Roth, T Vogl, F A J van de Loo, M I Koenders, W B van den Berg, P M van der Kraan, P L E M van Lent |
Journal | Osteoarthritis and cartilage
(Osteoarthritis Cartilage)
Vol. 25
Issue 1
Pg. 118-127
(01 2017)
ISSN: 1522-9653 [Electronic] England |
PMID | 27514996
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Calgranulin A
- Calgranulin B
- Lipoproteins, LDL
- Transforming Growth Factor beta
|
Topics |
- Animals
- Calgranulin A
(metabolism)
- Calgranulin B
(metabolism)
- Humans
- Injections, Intra-Articular
- Lipoproteins, LDL
(administration & dosage, pharmacology)
- Macrophages
(drug effects, physiology)
- Mice
- Mice, Inbred C57BL
- Osteoarthritis
(metabolism)
- Synovial Fluid
(cytology, physiology)
- Transforming Growth Factor beta
(physiology)
|